Evidence map›Paper›PMID 28668544›Full record

ArticlePreventive medicine2017

The potential impact of cannabis legalization on the development of cannabis use disorders.

Alan J Budney, Jacob T Borodovsky

Abstract read
In one paragraph

Article in Preventive medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Perceptions about cannabis use during pregnancy: a rapid best-framework qualitative synthesis.Canadian journal of public health = Revue canadienne de sante publique · 2021
    Pooled it
  4. Characterizing cannabis use reduction and change in functioning during treatment: Initial steps on the path to new clinical endpoints.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2022
    Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Cannabis use among hospitalised adolescents before and after decriminalisation in South Africa.The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Cannabis legalization in the U.S. Where do we go from here?Trends in psychiatry and psychotherapy · 2022
    Article
  14. Article
  15. Article
  16. Associations of mode of administration on cannabis consumption and subjective intoxication in daily life.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Alan J BudneyGeisel School of Medicine at Dartmouth, Center for Technology and Behavioral Health, 46 Centerra Parkway, Lebanon, NH 03766, United States. Electronic address: Alan.J.Budney@dartmouth.edu.
Jacob T BorodovskyGeisel School of Medicine at Dartmouth, Center for Technology and Behavioral Health, 46 Centerra Parkway, Lebanon, NH 03766, United States; The Dartmouth Institute for Health Policy and Clinical Practice, 74 College St., Hanover, NH 03755, United States.

Funding

Treatment Development & Evaluation CoreP30DA029926 · NIDA · DARTMOUTH COLLEGE · PI Lisa A. Marsch · 2011 to 2026
$21.5M
Behavioral Treatment of Adolescent Marijuana UseR01DA015186 · NIDA · UNIV OF ARKANSAS FOR MED SCIS · PI BUDNEY, ALAN JEFFREY · 2002 to 2017
$7.7M
Training in the Science of Co-Occurring DisordersT32DA037202 · NIDA · DARTMOUTH COLLEGE · PI Lisa A. Marsch · 2014 to 2026
$4.7M
Targeting tobacco cessation during treatment for cannabis use disordersR01DA032243 · NIDA · DARTMOUTH COLLEGE · PI BUDNEY, ALAN JEFFREY · 2012 to 2015
$1.7M
NIDA NIH HHS P30 DA029926NIDA NIH HHS R01 DA015186NIDA NIH HHS R01 DA032243NIDA NIH HHS T32 DA037202
6 · The paper itself

Abstract

Specific provisions of legal cannabis legislation and regulation could influence cannabis initiation, frequency and quantity of use, and progression to cannabis use disorder. This brief essay highlights scientifically based principles and risk factors that underlie substance use and addiction that can be leveraged to inform policies that might mitigate the development and consequences of cannabis use disorder. Specifically, pharmacologic, access/availability, and environmental factors are discussed in relation to their influence on substance use disorders to illustrate how regulatory provisions can differentially affect these factors and risk for addiction. Relevant knowledge from research and experience with alcohol and tobacco regulation are also considered. Research designed to inform regulatory policy and to evaluate the impact of cannabis legislation on cannabis use and problems is progressing. However, definitive findings will come slowly, and more concerted efforts and resources are needed to expedite this process. In the meantime, policymakers should take advantage of the large body of scientific literature on substance use to foster empirically-guided, common sense approaches to cannabis policy that focus on prevention of addiction.

Indexed as

CannabisLegislation, DrugMarijuana AbuseBehavior, AddictiveHumansMarijuana SmokingPublic PolicyRisk FactorsAddictionCannabisLegalizationMarijuanaPolicyPreventionRegulation

Identifiers

PMID28668544
PMCPMC5735001

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.